NextGen In-Vitro Diagnostics Pvt. Ltd.

NGIVD (NextGen Invitro Diagnostics Pvt Ltd) is a healthcare company based in India that focuses on in vitro diagnostics (IVD) using advanced multiplexing technology. The company aims to provide precise, accessible, and affordable diagnostic solutions for infectious and vector-borne diseases, including Tuberculosis, Malaria, Dengue, and Chikungunya. NGIVD specializes in developing molecular diagnostic products that allow for the detection of multiple disease markers from a single sample. This approach enhances diagnostic speed, accuracy, and cost-effectiveness, enabling healthcare providers to make informed treatment decisions. Their product offerings include nucleic acid isolation kits, molecular transport media, clinical chemistry reagents, ELISA kits, and point-of-care diagnostic kits. The company serves a diverse customer base, including healthcare providers, research institutions, and diagnostic laboratories. NGIVD is committed to innovation and quality, supported by collaborations with organizations like BIRAC and USISTEF. Their mission is to expand access to advanced diagnostic technologies, improving health outcomes, especially in resource-limited settings.

• Employees 25
• Founded 2015